BioTime Inc (NYSE MKT LLC:BTX)

4.62
BATS BZX Real-Time Price
As of 11:10am ET
 +0.04 / +0.87%
Today’s Change
2.29
Today|||52-Week Range
5.95
+23.86%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$374.7M

Company Description

BioTime, Inc. is a biotechnology company, which is focused on regenerative medicine and blood plasma volume expanders. The company provides research and product development in the field of regenerative medicine. It develops blood plasma volume expanders, blood replacement solutions for hypothermic surgery and technology for use in surgery, emergency trauma treatment and other applications. The company focuses in the field of emerging field of regenerative medicine; specifically human embryonic stem cell and induced pluripotent stem cell technology. BioTime was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Alameda, CA.

Contact Information

BioTime, Inc.
1301 Harbor Bay Parkway
Alameda California 94502
P:(510) 521-3390
Investor Relations:
5105213390367

Employees

Shareholders

Mutual fund holders5.58%
Other institutional41.27%
Individual stakeholders35.43%

Top Executives

Michael D. WestPresident, Chief Executive Officer & Director
Aditya P. MohantyChief Operating Officer
Robert W. PeabodyChief Financial Officer & Senior Vice President
Hal SternbergVice President-Research
Judith SegallSecretary, Director & VP-Administration

To view my watchlist

Not a member yet?

Sign up now for a free account